Cargando…

Lewis y antigen promotes p27 degradation by regulating ubiquitin-proteasome activity

As a tumor-associated carbohydrate antigen, elevated expression of Lewis y promotes the malignant behaviors of tumor cells. Although our preliminary study showed that the increased expression of Lewis y antigen decreased the expression of cell cycle inhibitor protein p27, the relevant mechanism rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Mingbo, Jin, Shan, Deng, Lu, Zhu, Liancheng, Hu, Zhenhua, Liu, Dawo, Liu, Juanjuan, Tan, Mingzi, Gao, Jian, Wang, Huimin, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746365/ https://www.ncbi.nlm.nih.gov/pubmed/29299130 http://dx.doi.org/10.18632/oncotarget.22617

Ejemplares similares

Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers
por: Zhang, Danye, et al.
Publicado: (2013)

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
por: Hao, Yingying, et al.
Publicado: (2017)

Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma
por: Zhuang, Huiyu, et al.
Publicado: (2013)

The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells
por: Hu, Zhenhua, et al.
Publicado: (2016)

Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
por: Zhuang, Huiyu, et al.
Publicado: (2014)

Beclin 1 Expression in Ovarian Tissues and Its Effects on Ovarian Cancer Prognosis
por: Cai, Mingbo, et al.
Publicado: (2014)

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway
por: Liu, Juanjuan, et al.
Publicado: (2009)

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers
por: Hu, Zhenhua, et al.
Publicado: (2013)

Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance
por: Gao, Jian, et al.
Publicado: (2013)

The Stimulation of IGF-1R Expression by Lewis(y) Antigen Provides a Powerful Development Mechanism of Epithelial Ovarian Carcinoma
por: Liu, Dawo, et al.
Publicado: (2011)

TRIM27 Negatively Regulates NOD2 by Ubiquitination and Proteasomal Degradation
por: Zurek, Birte, et al.
Publicado: (2012)

Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression
por: Hou, Rui, et al.
Publicado: (2017)

Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration
por: Wang, Jing, et al.
Publicado: (2019)

Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors
por: Liu, Chuan, et al.
Publicado: (2012)

Expression of HE4 in Endometrial Cancer and Its Clinical Significance
por: Li, Xiao, et al.
Publicado: (2015)

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”
por: Li, Xiao, et al.
Publicado: (2018)

Elevated Levels of Lewis Y and Integrin α(5)β(1) Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma
por: Hu, Zhenhua, et al.
Publicado: (2012)

Increase in Docetaxel-Resistance of Ovarian Carcinoma-Derived RMG-1 Cells with Enhanced Expression of Lewis Y Antigen
por: Zhang, Fan, et al.
Publicado: (2011)

SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation
por: Zhao, Ganye, et al.
Publicado: (2016)

Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma
por: Wang, Huimin, et al.
Publicado: (2016)

Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways
por: Liu, Dawo, et al.
Publicado: (2012)

Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway
por: Ben-Nissan, Gili, et al.
Publicado: (2014)

The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease
por: Nath, Samir R., et al.
Publicado: (2017)

Multi-Step Ubiquitin Decoding Mechanism for Proteasomal Degradation
por: Tsuchiya, Hikaru, et al.
Publicado: (2020)

How the 26S Proteasome Degrades Ubiquitinated Proteins in the Cell
por: Coll-Martínez, Bernat, et al.
Publicado: (2019)

Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
por: Abbas, Ruqaia, et al.
Publicado: (2021)

Ubiquitin-Proteasome System–Regulated Protein Degradation in Spermatogenesis
por: Xiong, Yi, et al.
Publicado: (2022)

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation
por: Lindsten, Kristina, et al.
Publicado: (2002)

Proteins Directly Interacting with Mammalian 20S Proteasomal Subunits and Ubiquitin-Independent Proteasomal Degradation
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2014)

Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
por: Chen, Qiyi, et al.
Publicado: (2011)

The Roles of Ubiquitin-Binding Protein Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome System and Autophagy
por: Zientara-Rytter, Katarzyna, et al.
Publicado: (2019)

Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
por: Korolchuk, Viktor I., et al.
Publicado: (2009)

Ribosomal proteins produced in excess are degraded by the ubiquitin–proteasome system
por: Sung, Min-Kyung, et al.
Publicado: (2016)

Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins
por: Abi Habib, Joanna, et al.
Publicado: (2020)

Ubiquitin-mediated proteasome degradation regulates optic fissure fusion
por: Pereira Piedade, Warlen, et al.
Publicado: (2019)

The yeast mitophagy receptor Atg32 is ubiquitinated and degraded by the proteasome
por: Camougrand, Nadine, et al.
Publicado: (2020)

Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021)

Ubiquitin-independent proteasomal degradation driven by C-degron pathways
por: Makaros, Yaara, et al.
Publicado: (2023)

Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions
por: Bialek, Wojciech, et al.
Publicado: (2023)

The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation
por: Gu, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qno16j74f16lp2fuieqvthil2r